Your session is about to expire
← Back to Search
Ablative Therapy for Oligoprogressive Cancer (VALOROUS Trial)
VALOROUS Trial Summary
This trial studies the effectiveness of adding localized treatments to systemic therapy for solid tumors that have not spread widely. The results will measure how long treatment lasts.
VALOROUS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowVALOROUS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.VALOROUS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there still openings for attendees in this research project?
"Affirmative. Information on clinicaltrials.gov confirms that the research project, which was initially published on October 5th 2023 is currently recruiting participants. Approximately 250 individuals need to be enrolled from 1 different medical facility."
How many participants can the study accommodate in total?
"Yes, the evidence on clinicaltrials.gov implies that this research is presently enrolling volunteers. The trial was initially posted on October 5th 2023 and most recently updated on October 19th of the same year. Approximately 250 subjects must be recruited from 1 location."
Share this study with friends
Copy Link
Messenger